User profiles for B Hirschel
Bernard HirschelVerified email at hirschel.ch Cited by 42774 |
Immunological recovery and antiretroviral therapy in HIV-1 infection
M Battegay, R Nüesch, B Hirschel… - The Lancet infectious …, 2006 - thelancet.com
… B—moderate evidence for efficacy or strong evidence for efficacy, but only limited clinical
benefit, supports recommendation for use; should usually be offered. C—evidence for efficacy …
benefit, supports recommendation for use; should usually be offered. C—evidence for efficacy …
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
…, P Burgisser, P Erb, K Boggian, JC Piffaretti, B Hirschel… - The Lancet, 2000 - thelancet.com
Background Hepatitis C virus (HCV) infection is highly prevalent among HIV-1-infected
individuals, but its contribution to the morbidity and mortality of coinfected patients who receive …
individuals, but its contribution to the morbidity and mortality of coinfected patients who receive …
Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases
…, JH Saurat, H Stalder, B Hirschel… - Clinical Infectious …, 1993 - academic.oup.com
… We have diagnosed simultaneous hepatitis B virus infection in only one of 30 patients
who repeatedly underwent serological testing for acute hepatitis A, B, C, and D and acute …
who repeatedly underwent serological testing for acute hepatitis A, B, C, and D and acute …
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
…, B Hirschel, R Malinverni, D Moradpour, B Müllhaupt… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Hepatitis C virus (HCV) induces chronic infection in 50% to 80% of
infected persons; approximately 50% of these do not respond to therapy. We performed a …
infected persons; approximately 50% of these do not respond to therapy. We performed a …
GRANULATION TISSUE AS A CONTRACTILE ORGAN: ASTUDY OF STRUCTURE AND FUNCTION
G Gabbiani, BJ Hirschel, GB Ryan, PR Statkov… - The Journal of …, 1972 - rupress.org
Contracting granulation tissues contain fibroblasts that develop characteristics typical of
smooth muscle: (a) They contain an extensive cytoplasmic fibrillar system. (b) They show …
smooth muscle: (a) They contain an extensive cytoplasmic fibrillar system. (b) They show …
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
…, B Hirschel, M Cavassini, B Bertisch… - Clinical infectious …, 2011 - academic.oup.com
… Active hepatitis B virus (HBV) infection was defined as positive HBV surface antigen or
HBV e antigen or HBV DNA. Hepatitis C virus (HCV) infection was defined as positive HCV …
HBV e antigen or HBV DNA. Hepatitis C virus (HCV) infection was defined as positive HCV …
Contraction of granulation tissue in vitro: similarity to smooth muscle
G Majno, G Gabbiani, BJ Hirschel, GB Ryan… - Science, 1971 - science.org
Strips of granulation tissue from three different experimental models contract in vitro when
treated with substances that induce contraction of smooth muscle. Because the fibroblasts in …
treated with substances that induce contraction of smooth muscle. Because the fibroblasts in …
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
…, V Schiffer, A Calmy, JP Chave, E Giacobini, B Hirschel… - Aids, 2010 - journals.lww.com
… , Rapid Visual Information Processing, and Spatial Working Memory from the Cambridge
Neuropsychological Test Automated Battery [18] , the Trail Making Test (TMT) parts A and B [19…
Neuropsychological Test Automated Battery [18] , the Trail Making Test (TMT) parts A and B [19…
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
B Ledergerber, M Egger, V Erard, R Weber, B Hirschel… - Jama, 1999 - jamanetwork.com
ContextAcquired immunodeficiency syndrome–related opportunistic illnesses (OIs)
continue to occur after initiation of potent antiretroviral therapy in patients with human …
continue to occur after initiation of potent antiretroviral therapy in patients with human …